BeiGene, Ltd.
Utility Patent Applications
Last updated:
List of all BeiGene, Ltd. patents 35 in total
| Status | Patent |
|---|---|
Application | Utility: DEGRADATION OF BRUTON'S TYROSINE KINASE (BTK) BY CONJUGATION OF BTK INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE Filling date: 26 Sep 2025 Issue date: 8 Sep 2022 |
Application | Utility: TRICYCLIC COMPOUNDS AS HPK1 INHIBITOR AND THE USE THEREOF Filling date: 26 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: PYRROLO[2,3-b]PYRAZINES AS HPK1 INHIBITOR AND THE USE THEREOF Filling date: 26 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: CYCLIC DINUCLEOTIDES AS STING AGONISTS Filling date: 26 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: PARP INHIBITOR PELLET PREPARATION AND PREPARATION PROCESS THEREFOR Filling date: 26 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: AMIDE-SUBSTITUTED IMIDAZO COMPOUNDS AS SELECTIVE INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASES Filling date: 26 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: ANTI-TIGIT ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS Filling date: 26 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: ANTI-TIM-3 ANTIBODIES AND USE THEREOF Filling date: 26 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: IMIDAZO[2,1-F][1,2,4]TRIAZIN-4-AMINE DERIVATIVES AS TLR7 AGONIST Filling date: 26 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: STABLE SOLID DISPERSION OF A B-RAF KINASE DIMER INHIBITOR, METHODS OF PREPARATION, AND USES THEREFOR Filling date: 26 Sep 2025 Issue date: 7 Apr 2022 |
Application | Utility: IMIDAZO[1,5-a]PYRAZINE DERIVATIVES AS PI3K DELTA INHIBITORS Filling date: 26 Sep 2025 Issue date: 31 Mar 2022 |
Application | Utility: IMIDAZO[1,5-A]PYRAZINE DERIVATIVES AS PI3KDELTA INHIBITORS Filling date: 26 Sep 2025 Issue date: 17 Mar 2022 |
Application | Utility: CRYSTALLINE FORMS OF (S)-7-(1-(BUT-2-YNOYL)PIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRAHY- DROPYRAZOLO[1,5-a]PYRIMIDINE-3-CARBOXAMIDE, PREPARATION, AND USES THEREOF Filling date: 26 Sep 2025 Issue date: 28 Oct 2021 |
Application | Utility: PYRAZOLOTRIAZOLOPYRIMIDINE DERIVATIVES AS A2A RECEPTOR ANTAGONIST Filling date: 26 Sep 2025 Issue date: 30 Sep 2021 |
Application | Utility: TREATMENT CANCERS USING A COMBINATION COMPRISING BTK INHIBITORS Filling date: 26 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: BCL-2 INHIBITORS Filling date: 26 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: COMBINATION OF A PD-1 ANTAGONIST AND A RAF INHIBITOR FOR TREATING CANCER Filling date: 26 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: ANTI-OX40 ANTIBODIES AND METHODS OF USE Filling date: 26 Sep 2025 Issue date: 15 Jul 2021 |
Application | Utility: MAINTENANCE THERAPY OF A PARP INHIBITOR IN TREATING GASTRIC CANCER Filling date: 26 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: PYRAZOLOTRIAZOLOPYRIMIDINE DERIVATIVES AS A2A RECEPTOR ANTAGONIST Filling date: 26 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: IMMUNOTHERAPY FOR HEPATOCELLULAR CARCINOMA Filling date: 26 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: IMMUNOMONOTHERAPY FOR UROTHELIAL CARCINOMA Filling date: 26 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: ANTI-TIGIT ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS Filling date: 26 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: NOVEL BENZOIMIDAZOLES AS SELECTIVE INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASES Filling date: 26 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: ANTI-PD-L1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS Filling date: 26 Sep 2025 Issue date: 10 Sep 2020 |
Application | Utility: IMIDAZO[1,5-A]PYRAZINE DERIVATIVES AS PI3KDELTA INHIBITORS Filling date: 26 Sep 2025 Issue date: 2 Jul 2020 |
Application | Utility: BTK INHIBITORS WITH IMPROVED DUAL SELECTIVITY Filling date: 26 Sep 2025 Issue date: 11 Jun 2020 |
Application | Utility: TREATMENT OF CANCERS USING A COMBINATION COMPRISING PARP INHIBITORS, TEMOZOLOMIDE AND/OR RADIATION THERAPY Filling date: 26 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: CRYSTALLINE FORMS OF SALTS OF FUSED TERA OR PENTA-CYCLIC DIHYDRODIAZEPINOCARAZOLONES, AND USES THEREOF Filling date: 26 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: COMBINATION OF A PD-1 ANTAGONIST AND A RAF INHIBITOR FOR TREATING CANCER Filling date: 26 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: TREATMENT CANCERS USING A COMBINATION COMPRISING PARP INHIBITORS Filling date: 26 Sep 2025 Issue date: 30 Jan 2020 |
Application | Utility: NOVEL 5 OR 8-SUBSTITUTED IMIDAZO [1,5-a] PYRIDINES AS SELECTIVE INHIBITORS OF INDOLEAMINE AND/OR TRYPTOPHANE 2,3-DIOXYGENASES Filling date: 26 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: IMIDAZO[1,5-a]PYRAZINE DERIVATIVES AS PI3K DELTA INHIBITORS Filling date: 26 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: NOVEL 5 OR 8-SUBSTITUTED IMIDAZO[1,5-a]PYRIDINES AS INDOLEAMINE AND/OR TRYPTOPHANE 2,3-DIOXYGENASES Filling date: 26 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: ANTI-TIM-3 ANTIBODIES AND USE THEREOF Filling date: 26 Sep 2025 Issue date: 12 Sep 2019 |
Showing 1 to 35 of 35 patents.